Anti-CASPR2 meningoencephalitis with thickened dura mater induced by various infections: A case report and literature review.

Publication date: Jun 20, 2025

With the update of novel autoantibodies and the expansion of the clinical spectrum, our understanding of autoimmune encephalitis (AE) is rapidly evolving. Anti-CASPR2 meningoencephalitis is a relatively rare condition that may be induced by infections. A young man presented with 3 episodes of meningoencephalitis potentially triggered by possible viral, Salmonella, and severe acute respiratory syndrome coronavirus 2. Neuroimaging revealed a thickening of the cerebral dura mater. Laboratory tests found positive serum CASPR2 antibodies in the third episode. Across all 3 episodes, similar clinical manifestations and imaging features were observed. Although autoantibodies in the previous 2 phases were negative, the possibility of infection-related anti-CASPR2 meningoencephalitis remains highly suspected. The treatment regimen comprised antimicrobial agents, corticosteroid therapy, intravenous immunoglobulin, and rituximab administration. Following treatment, the patient’s condition improved with no recurrence to date. Repeat testing showed undetectable anti-CASPR2 immunoglobulin G in both serum and cerebrospinal fluid. Post-treatment contrast-enhanced magnetic resonance imaging demonstrated the resolution of dural thickening. We further reviewed the mechanism of various infection-related AE and characteristics of CASPR2-related disease. To our knowledge, this is the first report of CASPR2 meningoencephalitis with thickened dura mater, indicating the importance of paying attention to antibody-negative AE and monitor antibodies repeatedly when necessary. In addition to immunotherapy, we recommend comprehensive management throughout the disease process.

Open Access PDF

Concepts Keywords
Antimicrobial Adult
Laboratory Autoantibodies
Meningoencephalitis Autoantibodies
Salmonella case report
Viral CASPR2
CNTNAP2 protein, human
COVID-19
Dura Mater
dura mater
Humans
infections
Magnetic Resonance Imaging
Male
Membrane Proteins
Membrane Proteins
Meningoencephalitis
meningoencephalitis
Nerve Tissue Proteins
Nerve Tissue Proteins
Rituximab
Rituximab

Semantics

Type Source Name
disease MESH meningoencephalitis
disease MESH infections
disease MESH autoimmune encephalitis
disease IDO infection
drug DRUGBANK Immune Globulin Human
drug DRUGBANK Rituximab
disease MESH recurrence
disease IDO process
disease MESH COVID 19
disease MESH herpes simplex
disease IDO bacteria
disease MESH severe acute respiratory syndrome
disease MESH encephalitis
drug DRUGBANK Azathioprine
drug DRUGBANK Coenzyme M
pathway REACTOME Reproduction
disease IDO history
drug DRUGBANK Ethanol
disease IDO blood
disease MESH abnormalities
disease IDO nucleic acid
drug DRUGBANK Methyl isocyanate
disease MESH carcinoma
disease MESH limbic encephalitis
disease MESH viral infection
drug DRUGBANK Acyclovir
drug DRUGBANK Olanzapine
drug DRUGBANK Phenobarbital
drug DRUGBANK Methylprednisolone

Original Article

(Visited 3 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *